CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo
- Authors
- Yoon, Hyung Ho; Ye, Sunghyeok; Lim, Sunhwa; Jo, Ara; Lee, Hawon; Hong, Felix; Lee, Seung Eun; Oh, Soo-Jin; Kim, Na-Rae; Kim, Kyoungmi; Kim, Bum-Joon; Kim, Hyunjin; Lee, C. Justin; Nam, Min-Ho; Hur, Junseok W.; Jeon, Sang Ryong
- Issue Date
- Feb-2022
- Publisher
- Mary Ann Liebert Inc.
- Citation
- CRISPR Journal, v.5, no.1, pp 95 - 108
- Pages
- 14
- Indexed
- SCIE
SCOPUS
- Journal Title
- CRISPR Journal
- Volume
- 5
- Number
- 1
- Start Page
- 95
- End Page
- 108
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/61035
- DOI
- 10.1089/crispr.2021.0025
- ISSN
- 2573-1599
2573-1602
- Abstract
- Mutations in specific genes, including synuclein alpha (SNCA) that encodes the alpha-synuclein protein, are known to be risk factors for sporadic Parkinson's disease (PD), as well as critical factors for familial PD. In particular, A53T-mutated SNCA (A53T-SNCA) is a well-studied familial pathologic mutation in PD. However, techniques for deletion of the mutated SNCA gene in vivo have not been developed. Here, we used the CRISPR-Cas9 system to delete A53T-SNCA in vitro as well as in vivo. Adeno-associated virus carrying SaCas9-KKH with a single-guide RNA targeting A53T-SNCA significantly reduced A53T-SNCA expression levels in vitro. Furthermore, we tested its therapeutic potential in vivo in a viral A53T-SNCA-overexpressing rat model of PD. Gene deletion of A53T-SNCA significantly rescued the overexpression of alpha-synuclein, reactive microgliosis, dopaminergic neurodegeneration, and parkinsonian motor symptoms. Our findings propose CRISPR-Cas9 system as a potential prevention strategy for A53T-SNCA-specific PD.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Neurosurgery > 1. Journal Articles
- 1. Basic Science > Department of Physiology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.